N8 recombinant Factor VIII

Factor VIII, recombinant · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for N8 recombinant Factor VIII, covering 2017-02-10 to 2017-02-10. Get the full timeline:

Most recent: Clinical Trial Update: A Single Dose Trial of Recombinant Factor VIII (N8) in Japanese Subjects With Haemophilia A: An Extension to Trial NN7008-3543 [Phase 1]

See pricing